Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Mid Cap | Pharmaceuticals & Drugs
1441.70
10.05 (0.70%) Cipla informs about Press Release
Date: 23-03-2015Cipla has informed regarding a Press Release dated March 23, 2015 titled 'Stempeutics receives Advanced Therapy Medicinal Product (ATMP) classification from European Medicines Agency (EMA) for its novel stem cell drug 'Stempeucel' '.
The above information is a part of company’s filings submitted to BSE.